Tyra Biosciences, Inc. SEC filings TYRA

Tyra Biosciences, Inc. has 426 filings in SEC EDGAR's recent list, going back to May 28, 2021. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 15, 2026 (other events). The company's fiscal year ends on December 31.

Form Description Filed Period
424B5 Prospectus supplement Sep 15, 2026 —
FWP Free writing prospectus Sep 14, 2026 —
S-3ASR Automatic shelf registration Sep 14, 2026 —
424B5 Prospectus supplement Aug 4, 2026 —
S-3 Shelf registration May 8, 2025 —
S-8 Employee stock plan registration Mar 19, 2024 —
S-3 Shelf registration Mar 19, 2024 —
S-3 Shelf registration Oct 3, 2022 —
S-8 Employee stock plan registration Sep 15, 2021 —
424B4 Prospectus Sep 15, 2021 —
S-1MEF Filing Sep 14, 2021 —
S-1/A Amended registration statement Sep 14, 2021 —
S-1/A Amended registration statement Sep 9, 2021 —
S-1 Registration statement Aug 20, 2021 —

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
TYRA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Carlsbad, CA
SEC filer status
, Emerging growth company
SEC CIK
1863127

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.